Newsletter Archive

61. 04.11.26 -- Life Science Leader Best Of March 4/11/2026
    04/11/26 Life Science Leader Newsletter
62. 04.10.26 -- Regulatory Flexibility In CGT: Key Shifts And Implications With Monika Swietlicka 4/10/2026
    04/10/26 Life Science Leader Newsletter
63. 04.09.26 -- Advancing Next-Generation Biologics: From Cell Line Innovation To Complex Modalities 4/9/2026

    04/09/26 Life Science Leader Newsletter

64. 04.08.26 -- Investing In Early-Stage Oncology With Yosemite's Dan McHugh 4/8/2026
    04/08/26
65. 04.07.26 -- ERP Solutions For Pharmaceutical Manufacturers 4/7/2026

    04/07/26

66. 04.06.26 -- The Silent Strategist: AI's "Hidden" Nudges Reshape Pipeline Strategy 4/6/2026
    04/06/26
67. 04.03.26 -- New Podcast Episodes: Regenerative Skin Therapy, Orally Available Biologics, Regulatory Flexibility In CGT, and More 4/3/2026
    04/03/26
68. 04.01.26 -- Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash 4/1/2026
    04/01/26
69. 03.30.26 -- Unlocking The Therapeutic Power Of Fibroblasts With Pete O'Heeron And Hamid Khoja, Ph.D. 3/30/2026
    03/30/26 Life Science Leader Newsletter
70. 03.26.26 -- A simple, helpful look at PUPSIT implementation. 3/26/2026

    03/26/26 Life Science Leader Newsletter